Año: 2023
Journal Impact Factor (JIF): 7.40
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
CLINICAL NEUROLOGY | SCIE | 17/280 | Q1 | T1 | D1 |
Año: 2023
Journal Citation Indicator (JCI): 1,880
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
CLINICAL NEUROLOGY | 16/281 | Q1 | T1 | D1 | 94,48 |
Año:
2023
CiteScore:
13,300
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Neurology | 8/192 | Q1 | T1 | D1 |
Neurology (clinical) | 19/400 | Q1 | T1 | D1 |
SJR año:
2023
Factor de Impacto:
2,464
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Neurology | 9/185 | Q1 | T1 | D1 |
Neurology (clinical) | 18/398 | Q1 | T1 | D1 |
Agencia | Código de Proyecto |
---|---|
4D Pharma | - |
AbbVie | - |
AcureX Therapeutics | - |
Aligning Science Across Parkinson's | - |
Allergan | - |
Amathus Therapeutics | - |
Avid Radiopharmaceuticals | - |
Bial Biotech | - |
Biogen | - |
BioLegend | - |
Bristol-Myers Squibb | - |
Calico Life Sciences | - |
Celgene Corporation | - |
Coave | - |
DeCapo Brainscience | - |
Denali Therapeutics | - |
Edmond J. Safra Foundation | - |
F. Hoffmann-La Roche | - |
GE Healthcare | - |
Genentech | - |
GlaxoSmithKline | - |
Golub Capital | - |
Handl Therapheutics | - |
Insitro | - |
Janssen Pharmaceuticals | - |
Lilly | - |
Lundbeck | - |
MerckCo | - |
Meso Scale Discovery | - |
Michael J. Fox Foundation for Parkinson's Research | - |
Neurocrine Biosciences | - |
Pfizer | - |
Piramal Imaging | - |
Prevail Therapeutics | - |
Sanofi Genzyme | - |
Servier | - |
Takeda Pharmaceutical Company | - |
Teva Neuroscience | - |
UCB | - |
Vanqua Bio | - |
Verily Life Sciences | - |
Voyager Therapeutics | - |
Yumanity Therapeutics | - |
# | Autor |
---|---|
1 | Muñoz-Delgado, L. |
2 | Labrador-Espinosa, M. Á. |
3 | Macías-García, D. |
4 | Jesús, S. |
5 | Benítez Zamora, B. |
6 | Fernández-Rodríguez, P. |
7 | Adarmes-Gómez, A. |
8 | Reina Castillo, M. I. |
9 | Castro-Labrador, S. |
10 | Silva-Rodríguez, J. |
11 | Carrillo, F. |
12 | García Solís, D. |
13 | |
14 |